DEA Telehealth Final Rules

About the 20-Minute Info Session

The Drug Enforcement Administration (DEA) is putting the finishing touches on three final rules related to prescribing medication via telemedicine. The current temporary rule expires at the end of 2025, which is an incentive for change. Is your organization prepared for compliance of future telehealth services under pending final rules?

During this on-demand live session, MedTrainer VP of Compliance Brian Williams discusses the changes between the temporary and proposed final rules, the importance of a permanent regulatory solution, potential challenges for providers and patients, and much more.

Watch the live session recording now to learn:

• What the DEA is hoping to accomplish

• Policy changes that may be required 

• Process improvements to remain compliant

• And more!